Skip to content

Exosome ncRNAs-based liquid biopsy for malignant characteristic assessment in patients with pulmonary nodule

Exosome ncRNAs-based liquid biopsy for malignant characteristic assessment in patients with pulmonary nodule

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16009614
Enrollment
Unknown
Registered
2016-10-26
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary nodule

Interventions

Gold Standard:
Index test:

Sponsors

Shanghai Tongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years; 2. Consistent with the diagnosis of asymptomatic pulmonary nodules (nodular diameter=3 cm); 3. voluntary participate the clinical research and sign on the informed consent.

Exclusion criteria

Exclusion criteria: 1. patients with other primary malignancies within 5 years; 2. Patients with serious diseases and severe dysfunction of the heart, liver, kidney; 3. Patients who are undergoing adjuvant chemotherapy, or underwent chemotherapy in the past; 4. pregnant or lactating women; 5. Patients with mental or cognitive impairment which influence the quality of life in this study; 6. Patients who are participating in other clinical trials; 7. Patients with poor compliance or other situations the researchers believe that is not eligible for inclusion.

Design outcomes

Primary

MeasureTime frame
Detection value;

Countries

China

Contacts

Public ContactZiqiang Zhang

Shanghai Tongji Hospital

zzq1419@126.com+86 18721335536

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026